At the news
? NEUTRALIMPACT 2/10 DEFA14A filed Apr 15, 2026 at 16:13 ET
Dexcom, Inc. has filed a definitive proxy statement (DEFA14A) for its upcoming annual shareholder meeting. The filing contains standard disclosures about director elections, executive compensation, and other corporate governance matters, but does not contain any material new information or announcements.
- Filing is a standard proxy statement (DEFA14A) for the annual shareholder meeting
- No new material information or announcements are included
- Contains standard disclosures about director elections and executive compensation
- Filing is routine and expected corporate governance documentation
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access